Sarcoidosis
-
Drug’s effectiveness for neurosarcoidosis studied
A drug commonly prescribed for Crohn’s disease and rheumatoid arthritis is also effective for treating neurosarcoidosis, according to new research led by Vanderbilt neurologists. Read MoreNov 16, 2017
-
Sarcoidosis research, patient care focus of newly created center
Vanderbilt University Medical Center (VUMC) has established a Sarcoidosis Center of Excellence under the direction of Wonder Drake, M.D., associate professor of Medicine and Pathology, Microbiology and Immunology. Read MoreNov 17, 2016
-
ResearchMatch database includes sub-registry for rare sarcoidosis
All ResearchMatch volunteers who self-report as having sarcoidosis will be prompted to answer additional questions to enhance the matching of volunteers with research teams who are studying this condition. Read MoreOct 23, 2014
-
A path to sarcoidosis treatment
Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis. Read MoreSep 25, 2014
-
Sarcoidosis research finds promising oral therapy
VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control. Read MoreSep 5, 2013
-
Bacterial signals in sarcoidosis
Study adds evidence for infectious agents’ role in sarcoidosis, an inflammatory condition that can lead to respiratory failure and death. Read MoreNov 6, 2012